Skip to main content
PMC home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1998 Jul;44:1481–1488.

Helicobacter pylori and peptic ulcer disease. Current evidence for management strategies.

N Chiba 1, R Lahaie 1, R N Fedorak 1, R Bailey 1, S J Veldhuyzen van Zanten 1, B Bernucci 1
PMCID: PMC2277552  PMID: 9678277

Abstract

OBJECTIVE: To review current evidence for primary care physicians who manage Helicobacter pylori in peptic ulcer disease. QUALITY OF EVIDENCE: MEDLINE was searched to August 1997 for randomized controlled trials, systematic overviews, and consensus reports. High-quality recent reviews were often found. Randomized controlled trials presented as abstracts at recent meetings were reviewed. MAIN FINDINGS: Helicobacter pylori is found in most case of duodental and gastric ulcer, and eradication of H pylori leads to "cure" of ulcer disease and prevention of ulcer complications. Eradication of H pylori is not indicated for gastroesophageal reflux disease. No evidence indicates that screening asymptomatic individuals for H pylori infection reduces the risk of subsequent development of gastric cancer. Controversial areas are the role of H pylori in functional dyspepsia and screening for H pylori before initiating nonsteroidal anti-inflammatory drugs. In primary care, H pylori can be detected using serologic tests or urea breath tests (UBT), but only UBTs can be used to confirm eradication. Whether patients suspected of having ulcers can be managed with an H pylori test-and-treat strategy without initial investigation is controversial. The first-line recommended treatment is 1 week of twice daily triple therapy with a proton pump inhibitor, clarithromycin (Biaxin), and amoxicillin (e.g., Amoxil), or metronidazole (Flagyl). CONCLUSIONS: Helicobacter pylori eradication should be first-line therapy in primary care for infected patients with peptic ulcers. Effective H pylori testing methods and treatments are now available.

Full text

PDF
1485

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antoine C., Lozniewski A., De Korwin J. D., Conroy M. C., Feldman L., Duprez A., Weber M. Etude comparative de quatre méthodes sérologiques commercialisées pour le diagnostic de l'infection gastrique à Helicobacter pylori. Gastroenterol Clin Biol. 1995 Feb;19(2):182–188. [PubMed] [Google Scholar]
  2. Chan F. K., Sung J. J., Chung S. C., To K. F., Yung M. Y., Leung V. K., Lee Y. T., Chan C. S., Li E. K., Woo J. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet. 1997 Oct 4;350(9083):975–979. doi: 10.1016/s0140-6736(97)04523-6. [DOI] [PubMed] [Google Scholar]
  3. Cotton P. B., Shorvon P. J. Analysis of endoscopy and radiography in the diagnosis, follow-up and treatment of peptic ulcer disease. Clin Gastroenterol. 1984 May;13(2):383–403. [PubMed] [Google Scholar]
  4. Cutler A. F., Havstad S., Ma C. K., Blaser M. J., Perez-Perez G. I., Schubert T. T. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology. 1995 Jul;109(1):136–141. doi: 10.1016/0016-5085(95)90278-3. [DOI] [PubMed] [Google Scholar]
  5. DeLuca V. A., Jr, Winnan G. G., Sheahan D. G., Sanders F. J., Jr, Greenlaw R., Marignani P., Gorelick F. S., Bhalotra R., Goldblatt R. S. Is gastroduodenitis part of the spectrum of peptic ulcer disease? J Clin Gastroenterol. 1981;3(Suppl 2):17–22. [PubMed] [Google Scholar]
  6. Desroches J. J., Lahaie R. G., Picard M., Morais J., Dumont A., Gaudreau C., Picard D., Chartrand R. Methodological validation and clinical usefulness of carbon-14-urea breath test for documentation of presence and eradication of Helicobacter pylori infection. J Nucl Med. 1997 Jul;38(7):1141–1145. [PubMed] [Google Scholar]
  7. Hawkey C. J., Karrasch J. A., Szczepañski L., Walker D. G., Barkun A., Swannell A. J., Yeomans N. D. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. N Engl J Med. 1998 Mar 12;338(11):727–734. doi: 10.1056/NEJM199803123381105. [DOI] [PubMed] [Google Scholar]
  8. Hopkins R. J., Girardi L. S., Turney E. A. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology. 1996 Apr;110(4):1244–1252. doi: 10.1053/gast.1996.v110.pm8613015. [DOI] [PubMed] [Google Scholar]
  9. Hosking S. W., Ling T. K., Chung S. C., Yung M. Y., Cheng A. F., Sung J. J., Li A. K. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomised controlled trial. Lancet. 1994 Feb 26;343(8896):508–510. doi: 10.1016/s0140-6736(94)91460-5. [DOI] [PubMed] [Google Scholar]
  10. Imperiale T. F., Speroff T., Cebul R. D., McCullough A. J. A cost analysis of alternative treatments for duodenal ulcer. Ann Intern Med. 1995 Nov 1;123(9):665–672. doi: 10.7326/0003-4819-123-9-199511010-00004. [DOI] [PubMed] [Google Scholar]
  11. Jaspersen D., Koerner T., Schorr W., Brennenstuhl M., Raschka C., Hammar C. H. Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc. 1995 Jan;41(1):5–7. doi: 10.1016/s0016-5107(95)70267-9. [DOI] [PubMed] [Google Scholar]
  12. Kang J. Y., Fock K. M., Ng H. S., Ho K. T., Chee A. Working Party report of the Gastroenterological Society of Singapore. Part I--Helicobacter pylori and peptic ulcer disease in Singapore. Singapore Med J. 1996 Jun;37(3):304–306. [PubMed] [Google Scholar]
  13. Labenz J., Börsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion. 1994;55(1):19–23. doi: 10.1159/000201117. [DOI] [PubMed] [Google Scholar]
  14. Laufer I. Assessment of the accuracy of double contrast gastroduodenal radiology. Gastroenterology. 1976 Nov;71(5):874–878. [PubMed] [Google Scholar]
  15. Lind T., Veldhuyzen van Zanten S., Unge P., Spiller R., Bayerdörffer E., O'Morain C., Bardhan K. D., Bradette M., Chiba N., Wrangstadh M. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter. 1996 Sep;1(3):138–144. doi: 10.1111/j.1523-5378.1996.tb00027.x. [DOI] [PubMed] [Google Scholar]
  16. Marshall B. J., Plankey M. W., Hoffman S. R., Boyd C. L., Dye K. R., Frierson H. F., Jr, Guerrant R. L., McCallum R. W. A 20-minute breath test for helicobacter pylori. Am J Gastroenterol. 1991 Apr;86(4):438–445. [PubMed] [Google Scholar]
  17. Mion F., Delecluse H. J., Rousseau M., Berger F., Brazier J. L., Minaire Y. Test respiratoire à l'urée-13C pour le diagnostic de l'infection à Helicobacter pylori. Comparaison avec l'histologie. Gastroenterol Clin Biol. 1994;18(12):1106–1111. [PubMed] [Google Scholar]
  18. O'Brien B., Goeree R., Mohamed A. H., Hunt R. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada. Arch Intern Med. 1995 Oct 9;155(18):1958–1964. [PubMed] [Google Scholar]
  21. Petersen H., Johannessen T., Kleveland P. M., Fjøsne U., Dybdahl J. H., Waldum H. L. Do we need to listen to the patient? The predictive value of symptoms. Scand J Gastroenterol Suppl. 1988;155:30–36. doi: 10.3109/00365528809096278. [DOI] [PubMed] [Google Scholar]
  22. Peterson W. L., Ciociola A. A., Sykes D. L., McSorley D. J., Webb D. D. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group. Aliment Pharmacol Ther. 1996 Jun;10(3):251–261. doi: 10.1111/j.0953-0673.1996.00251.x. [DOI] [PubMed] [Google Scholar]
  23. Pineau B. C., Pattee L. P., McGuire S., Sekar A., Scully L. J. Unusual presentation of primary sclerosing cholangitis. Can J Gastroenterol. 1997 Jan-Feb;11(1):45–48. doi: 10.1155/1997/948191. [DOI] [PubMed] [Google Scholar]
  24. Rokkas T., Karameris A., Mavrogeorgis A., Rallis E., Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc. 1995 Jan;41(1):1–4. doi: 10.1016/s0016-5107(95)70266-0. [DOI] [PubMed] [Google Scholar]
  25. Ross P., Dutton A. M. Computer analysis of symptom complexes in patients having upper gastrointestinal examinations. Am J Dig Dis. 1972 Mar;17(3):248–254. doi: 10.1007/BF02232297. [DOI] [PubMed] [Google Scholar]
  26. Sipponen P., Varis K., Fräki O., Korri U. M., Seppälä K., Siurala M. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients. Scand J Gastroenterol. 1990 Oct;25(10):966–973. doi: 10.3109/00365529008997621. [DOI] [PubMed] [Google Scholar]
  27. Talley N. J. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia. Gastroenterology. 1994 May;106(5):1174–1183. doi: 10.1016/0016-5085(94)90007-8. [DOI] [PubMed] [Google Scholar]
  28. Talley N. J., Kost L., Haddad A., Zinsmeister A. R. Comparison of commercial serological tests for detection of Helicobacter pylori antibodies. J Clin Microbiol. 1992 Dec;30(12):3146–3150. doi: 10.1128/jcm.30.12.3146-3150.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Trespi E., Broglia F., Villani L., Luinetti O., Fiocca R., Solcia E. Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication. Scand J Gastroenterol. 1994 Oct;29(10):884–888. doi: 10.3109/00365529409094858. [DOI] [PubMed] [Google Scholar]
  30. Tytgat G. N. Current indications for Helicobacter pylori eradication therapy. Scand J Gastroenterol Suppl. 1996;215:70–73. [PubMed] [Google Scholar]
  31. Unge P. Review of Helicobacter pylori eradication regimens. Scand J Gastroenterol Suppl. 1996;215:74–81. [PubMed] [Google Scholar]
  32. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983 Jun 4;1(8336):1273–1275. [PubMed] [Google Scholar]
  33. Vaira D., Miglioli M., Mulè P., Holton J., Menegatti M., Vergura M., Biasco G., Conte R., Logan R. P., Barbara L. Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut. 1994 Mar;35(3):309–312. doi: 10.1136/gut.35.3.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Veldhuyzen van Zanten S. J., Cleary C., Talley N. J., Peterson T. C., Nyrén O., Bradley L. A., Verlinden M., Tytgat G. N. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol. 1996 Apr;91(4):660–673. [PubMed] [Google Scholar]
  35. Veldhuyzen van Zanten S. J., Pollak P. T., Best L. M., Bezanson G. S., Marrie T. Increasing prevalence of Helicobacter pylori infection with age: continuous risk of infection in adults rather than cohort effect. J Infect Dis. 1994 Feb;169(2):434–437. doi: 10.1093/infdis/169.2.434. [DOI] [PubMed] [Google Scholar]
  36. Veldhuyzen van Zanten S. J., Sherman P. M. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: a systematic overview. CMAJ. 1994 Jan 15;150(2):177–185. [PMC free article] [PubMed] [Google Scholar]
  37. Veldhuyzen van Zanten S. J., Sherman P. M., Hunt R. H. Helicobacter pylori: new developments and treatments. CMAJ. 1997 Jun 1;156(11):1565–1574. [PMC free article] [PubMed] [Google Scholar]
  38. Veldhuyzen van Zanten S. J., Sherman P. M. Indications for treatment of Helicobacter pylori infection: a systematic overview. CMAJ. 1994 Jan 15;150(2):189–198. [PMC free article] [PubMed] [Google Scholar]
  39. Walsh J. H., Peterson W. L. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engl J Med. 1995 Oct 12;333(15):984–991. doi: 10.1056/NEJM199510123331508. [DOI] [PubMed] [Google Scholar]
  40. Wotherspoon A. C., Doglioni C., Diss T. C., Pan L., Moschini A., de Boni M., Isaacson P. G. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993 Sep 4;342(8871):575–577. doi: 10.1016/0140-6736(93)91409-f. [DOI] [PubMed] [Google Scholar]
  41. Yeomans N. D., Tulassay Z., Juhász L., Rácz I., Howard J. M., van Rensburg C. J., Swannell A. J., Hawkey C. J. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. N Engl J Med. 1998 Mar 12;338(11):719–726. doi: 10.1056/NEJM199803123381104. [DOI] [PubMed] [Google Scholar]
  42. de Boer W. A., van Etten R. J., Lai J. Y., Schneeberger P. M., van de Wouw B. A., Driessen W. M. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection. Helicobacter. 1996 Sep;1(3):145–150. doi: 10.1111/j.1523-5378.1996.tb00028.x. [DOI] [PubMed] [Google Scholar]
  43. de Boer W., Driessen W., Jansz A., Tytgat G. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet. 1995 Apr 1;345(8953):817–820. doi: 10.1016/s0140-6736(95)92962-2. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES